Key stats
About iShares Biotechnology ETF
Home page
Inception date
Feb 5, 2001
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
BlackRock Fund Advisors
Distributor
BlackRock Investments LLC
IBB tracks an index of US biotechnology companies listed on the major US exchanges. This includes companies engaged in the research and development of therapeutic treatments but are not focused on the commercialization and mass production of pharmaceutical drugs. This also includes companies that are engaged in the production of tools or systems that enable biotechnology processes. IBB includes companies of all capitalizations, and weights using a modified market-cap methodology. Individual holdings are subject to capping requirements, 8% on the five largest constituents and 4% for the remaining. The index is rebalanced quarterly and fully reconstituted annually in December. Prior to June 21, 2021, the fund was named iShares Nasdaq Biotechnology ETF and tracked the NASDAQ Biotechnology Index.
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region
Top 10 holdings
Has the Market Been Shitting On You?It's no secret that markets are tough to navigate right now. That is why I have been finding sectors with potential and direction. While this one only has one of those characteristics, it is waiting for volatility expansion, and all signs point to the downside.
We don't need to trade everyday but,
IBB - iShares Biotech EFT - SHORT (Wyckoff Redistribution)IBB looks to be in a Wyckoff Redistribution phase, with UTAD emerging currently.
On a larger time frame, looks as though a weekly H&S patter forming with the re-distribution section acting as the right shoulder.
My price target is $57, in line with the 1.618 fib extension.
IBB d2 accumulation buy/hold setup 40% gains🔸Hello guys, today let's review 2daily chart for IBB . Entering re-accumulation
stage now, expecting range bound trading during autumn time season.
Range defined by range highs set at 135 usd and range lows at 117 usd.
🔸Similar fractal observed in 2018/2019. Faded into range after heavy spike,
re-
IBB Entry, Volume, Target, Stop, ResistanceEntry: with price above 133.81
Volume: with volume greater than 1.67M
Target: 138.50 area
Stop: Depending on your risk tolerance; Based on an entry of 133.82, 132.25 gets you 3/1 Reward to Risk Ratio.
Resistance: 135 area
This swing trade idea is not trade advice and is strictly based on my ideas a
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related funds
Frequently Asked Questions
An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
IBB trades at 124.24 USD today, its price has risen 1.91% in the past 24 hours. Track more dynamics on IBB price chart.
IBB net asset value is 124.23 today — it's fallen 0.45% over the past month. NAV represents the total value of the fund's assets less liabilities and serves as a gauge of the fund's performance.
IBB assets under management is 5.23 B USD. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.
IBB price has risen by 0.37% over the last month, and its yearly performance shows a −6.76% decrease. See more dynamics on IBB price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −0.45% over the last month, showed a −9.26% decrease in three-month performance and has decreased by −7.10% in a year.
NAV returns, another gauge of an ETF dynamics, have fallen by −0.45% over the last month, showed a −9.26% decrease in three-month performance and has decreased by −7.10% in a year.
IBB fund flows account for −1.38 B USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
IBB invests in stocks. See more details in our Analysis section.
IBB expense ratio is 0.45%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.
No, IBB isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, IBB technical analysis shows the buy rating and its 1-week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating IBB shows the sell signal. See more of IBB technicals for a more comprehensive analysis.
Today, IBB technical analysis shows the buy rating and its 1-week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating IBB shows the sell signal. See more of IBB technicals for a more comprehensive analysis.
Yes, IBB pays dividends to its holders with the dividend yield of 0.31%.
IBB trades at a premium (0.00%).
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
IBB shares are issued by BlackRock, Inc.
IBB follows the NYSE Biotechnology (TR). ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on Feb 5, 2001.
The fund's management style is passive, meaning it's aiming to replicate the performance of the underlying index by holding assets in the same proportions as the index. The goal is to match the index's returns.